Romiplostim to raise low platelets after radiation therapy
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a new medication called romiplostim that may help raise your platelet count when it drops too low after radiation therapy. If you have a solid tumor and your platelets are below 75,000, this treatment could help you recover and avoid complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have a solid tumor (like lung, breast, or head and neck cancer).
- You have already had radiation therapy (radiotherapy) of at least 45 Gy, either alone or with chemo, and it lasted for at least two weeks.
- Your most recent blood test (within the last 3 days) shows a low platelet count (below 75,000).
- Your doctor expects you to live at least 12 more weeks and you are in good general condition (ECOG score 0-2).
- You are not pregnant and are willing to use birth control if you could have children.
- You have not taken certain medicines that raise platelets (like rhTPO or rhIL-11) in the last 4 weeks, and you have not had a platelet transfusion in the last 5 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called romiplostim to help raise platelet levels in children and young adults (ages 6–24) whose platelets drop due to chemotherapy. It’s for those with solid tumors or other non-marrow cancers who are still getting strong treatment.
This trial tests a drug called romiplostim for patients whose platelet counts stay very low (below 30) for a long time after chemotherapy, even after other treatments have failed. The goal is to see if romiplostim can help raise your platelet count to a safer level.
This trial tests a drug called romiplostim to prevent low platelet counts (a condition that raises bleeding risk) caused by chemotherapy in people with breast cancer. If you qualify, you may receive this drug to help keep your platelets at a safer level during future treatments.
This trial tests a new version of a drug called romiplostim to help raise platelet counts in breast cancer patients whose platelets drop because of chemotherapy. Raising your platelets may reduce the risk of bleeding and allow you to continue your cancer treatment.
This trial tests a drug called Romiplostim to help raise low platelet counts caused by leukemia treatment. It is for adults with leukemia whose platelets are below 50 and who may benefit from this therapy.
This study tests a new version of a platelet-boosting medicine (romiplostim) for people whose platelets drop during cancer treatment. The goal is to see if it can safely raise platelet counts so you can continue your therapy.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.